title: The use of OKT3 in the treatment of acute vascular rejection.
authors.affiliation: Department of Pathology, University of Cincinnati Medical Center, Ohio 45267-0714.
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: M A
authors.initials: MA
authors.lastname: Weiss
authors.forename: R D
authors.initials: RD
authors.lastname: Smith
authors.forename: G W
authors.initials: GW
authors.lastname: Stephens
authors.forename: M
authors.initials: M
authors.lastname: Carey
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001808:Blood Vessels / Q000276:immunology*; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods*; D016853:Muromonab-CD3
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D003404:Creatinine